| P2093 | author name string | Robert Kiss | |
| | Florence Lefranc | |
| | Véronique Mathieu | |
| | Marie Le Mercier | |
| | Shannon Fortin | |
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| | Galectin-3 as an immunohistochemical tool to distinguish pilocytic astrocytomas from diffuse astrocytomas, and glioblastomas from anaplastic oligodendrogliomas. | Q55471650 |
| | Expression of galectin-1 mRNA correlates with the malignant potential of human gliomas and expression of antisense galectin-1 inhibits the growth of 9 glioma cells. | Q55476008 |
| | Distribution of extracellular matrix proteins in primary human brain tumours: an immunohistochemical analysis. | Q55487243 |
| | Induction of allogenic T-cell hyporesponsiveness by galectin-1-mediated apoptotic and non-apoptotic mechanisms | Q74183464 |
| | Galectin 1 modulates attachment, spreading and migration of cultured vascular smooth muscle cells via interactions with cellular receptors and components of extracellular matrix | Q74526038 |
| | Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion | Q79097251 |
| | HIF-1 alpha is a regulator of galectin-3 expression in the intervertebral disc | Q80530258 |
| | Hypoxia influences the cellular cross-talk of human dermal fibroblasts. A proteomic approach | Q81372718 |
| | Galectin-1 knocking down in human U87 glioblastoma cells alters their gene expression pattern | Q40392221 |
| | Multifaceted role of galectin-3 on human glioblastoma cell motility | Q40489819 |
| | Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures | Q40797947 |
| | The role of integrins in the malignant phenotype of gliomas | Q40824234 |
| | Galectin 1 is involved in vascular smooth muscle cell proliferation | Q40892226 |
| | Expression pattern of galectin-3 in neural tumor cell lines | Q40893052 |
| | Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells | Q40933105 |
| | Diffuse brain invasion of glioma cells requires beta 1 integrins | Q41148090 |
| | Selective modulation of the interaction of alpha 7 beta 1 integrin with fibronectin and laminin by L-14 lectin during skeletal muscle differentiation. | Q41498859 |
| | The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells. | Q42003225 |
| | Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors | Q42485404 |
| | Adhesive and invasive features in gliomas | Q42496307 |
| | Molecular characterization of cell substratum attachments in human glial tumors relates to prognostic features | Q43825689 |
| | Galectin-1 interacts with beta-1 subunit of integrin. | Q44612331 |
| | The K.G. McKenzie award lecture--1986. Effects of extracellular matrix proteins on the growth and differentiation of an anaplastic glioma cell line | Q44710656 |
| | Apoptosis of T cells mediated by galectin-1. | Q46356564 |
| | Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27. | Q46654963 |
| | Galectin-8 binds specific beta1 integrins and induces polarized spreading highlighted by asymmetric lamellipodia in Jurkat T cells | Q46861486 |
| | Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege | Q47860342 |
| | Regulation of cellular adhesion to extracellular matrix proteins by galectin-3. | Q47999828 |
| | Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. | Q48077854 |
| | Galectins: a family of animal beta-galactoside-binding lectins | Q48084852 |
| | Galectin-3 and galectin-3-binding site expression in human adult astrocytic tumours and related angiogenesis | Q48119227 |
| | Galectin-3 labeling correlates positively in tumor cells and negatively in endothelial cells with malignancy and poor prognosis in oligodendroglioma patients. | Q48517137 |
| | Galectin-1 modulates human glioblastoma cell migration into the brain through modifications to the actin cytoskeleton and levels of expression of small GTPases | Q48543365 |
| | Expression of the endogenous galactose-binding protein galectin-3 correlates with the malignant potential of tumors in the central nervous system | Q48637099 |
| | Galectin-3: cellular distribution and correlation with WHO-grade in human gliomas | Q48731960 |
| | Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma | Q48958266 |
| | Galectins are differentially expressed in supratentorial pilocytic astrocytomas, astrocytomas, anaplastic astrocytomas and glioblastomas, and significantly modulate tumor astrocyte migration. | Q49108957 |
| | Phylogenetic analysis of the vertebrate galectin family. | Q51037036 |
| | Human galectin-2: expression profiling by RT-PCR/immunohistochemistry and its introduction as a histochemical tool for ligand localization. | Q54645960 |
| | NG2 proteoglycan promotes endothelial cell motility and angiogenesis via engagement of galectin-3 and alpha3beta1 integrin | Q24561606 |
| | Galectin-8 expression decreases in cancer compared with normal and dysplastic human colon tissue and acts significantly on human colon cancer cell migration as a suppressor | Q24670045 |
| | Integrins: bidirectional, allosteric signaling machines | Q27860700 |
| | Galectin-8 binding to integrins inhibits cell adhesion and induces apoptosis | Q28138246 |
| | Galectins and cancer | Q28201134 |
| | Ah, sweet mystery of death! Galectins and control of cell fate | Q28203010 |
| | The mystery of nonclassical protein secretion. A current view on cargo proteins and potential export routes | Q28204640 |
| | Role of galectin-8 as a modulator of cell adhesion and cell growth | Q28242002 |
| | Galectin-9 in physiological and pathological conditions | Q28242034 |
| | Galectins. Structure and function of a large family of animal lectins | Q28246794 |
| | Drug resistance and the solid tumor microenvironment | Q29614403 |
| | Astrocytoma adhesion to extracellular matrix: functional significance of integrin and focal adhesion kinase expression | Q30637622 |
| | Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression | Q30930851 |
| | Angiogenesis in gliomas: imaging and experimental therapeutics | Q31028310 |
| | Present and potential future issues in glioblastoma treatment | Q31043603 |
| | Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts | Q31169211 |
| | Galectins structure and function--a synopsis. | Q31974744 |
| | Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets | Q33212086 |
| | Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cells | Q33588193 |
| | The extracellular matrix of gliomas: modulation of cell function | Q33748808 |
| | Matrix metalloproteinases and their biological function in human gliomas | Q33778701 |
| | Secretion of the galectin family of mammalian carbohydrate-binding proteins | Q33783731 |
| | Cell adhesion molecules, signal transduction and cell growth | Q33796319 |
| | The ADAM gene family: surface proteins with adhesion and protease activity | Q33826746 |
| | RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction | Q33914018 |
| | Galectins as modulators of tumour progression | Q34381235 |
| | Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response? | Q34693483 |
| | Role of integrins in cell invasion and migration | Q35084782 |
| | Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment | Q35107972 |
| | Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy | Q35127584 |
| | FAK signaling in anaplastic astrocytoma and glioblastoma tumors | Q35144479 |
| | Molecular mechanisms of glioma invasiveness: the role of proteases | Q35166808 |
| | Introduction to galectins | Q35646606 |
| | Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion | Q35749727 |
| | Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis | Q35800467 |
| | Galectin-3 induces endothelial cell morphogenesis and angiogenesis | Q35809815 |
| | 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs | Q35812711 |
| | Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia. | Q35945071 |
| | SPARC upregulates MT1-MMP expression, MMP-2 activation, and the secretion and cleavage of galectin-3 in U87MG glioma cells | Q35995952 |
| | Galectin-1 as a potential cancer target | Q36078029 |
| | Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis | Q36084509 |
| | On the role of galectin-3 in cancer apoptosis | Q36103556 |
| | New roles for galectins in brain tumors--from prognostic markers to therapeutic targets | Q36136988 |
| | Tumor hypoxia and cancer progression. | Q36185821 |
| | Angiogenesis in gliomas: biology and molecular pathophysiology | Q36359221 |
| | The role of the extracellular matrix in angiogenesis in malignant glioma tumors | Q36359232 |
| | Proteases and glioma angiogenesis. | Q36359237 |
| | Galectin-7. | Q36375027 |
| | ER stress, hypoxia tolerance and tumor progression. | Q36393499 |
| | Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures | Q36481984 |
| | 'Pseudopalisading' necrosis in glioblastoma: a familiar morphologic feature that links vascular pathology, hypoxia, and angiogenesis | Q36510818 |
| | Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1 | Q36534647 |
| | Galectin-1: a small protein with major functions | Q36535706 |
| | UPR activation alters chemosensitivity of tumor cells | Q36544406 |
| | Can anti-migratory drugs be screened in vitro? A review of 2D and 3D assays for the quantitative analysis of cell migration | Q36556528 |
| | Galectin interactions with extracellular matrix and effects on cellular function | Q36667127 |
| | Anti-galectin compounds as potential anti-cancer drugs | Q36683470 |
| | Molecular targets of glioma invasion. | Q36720990 |
| | Galectins as modulators of tumor progression in head and neck squamous cell carcinomas | Q36742111 |
| | Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival | Q36819503 |
| | The role of galectin-3 in cancer drug resistance | Q36838457 |
| | Galectins in the tumor endothelium: opportunities for combined cancer therapy | Q36860244 |
| | Diffuse glioma growth: a guerilla war | Q36931690 |
| | Integrins: molecular determinants of glioma invasion | Q36978429 |
| | Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. | Q36986304 |
| | Hypoxia and cancer | Q37008506 |
| | Molecular pathology of malignant gliomas | Q37014747 |
| | Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer | Q37032635 |
| | Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas | Q37047723 |
| | The galectin family and digestive disease | Q37108003 |
| | Current status of clinical trials for glioblastoma. | Q37161208 |
| | Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression | Q37165859 |
| | Molecular basis of interaction between NG2 proteoglycan and galectin-3. | Q38317537 |
| | Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1). | Q38326047 |
| | Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death | Q38336667 |
| | Gene expression profiling of malignant mesothelioma. | Q38351552 |
| | Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration | Q38359998 |
| | The extracellular matrix of the central and peripheral nervous systems: structure and function | Q39652117 |
| | Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines | Q39955272 |
| | Runx2 is expressed in human glioma cells and mediates the expression of galectin-3. | Q39988093 |
| | Knocking down galectin 1 in human hs683 glioblastoma cells impairs both angiogenesis and endoplasmic reticulum stress responses | Q39989272 |
| | Detection of a hypersialylated beta1 integrin endogenously expressed in the human astrocytoma cell line A172. | Q39990303 |
| | Evidence of galectin-1 involvement in glioma chemoresistance | Q40006970 |
| | Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas | Q40091951 |
| | Galectin-1 expression in human glioma cells: modulation by ionizing radiation and effects on tumor cell proliferation and migration | Q40111279 |
| | Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma model | Q40134090 |
| | Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression | Q40176107 |
| | Proteomic analysis of hypoxia-induced responses in the syncytialization of human placental cell line BeWo | Q40209524 |
| | The small alpha5beta1 integrin antagonist, SJ749, reduces proliferation and clonogenicity of human astrocytoma cells | Q40267082 |
| | Galectin-3 regulates mitochondrial stability and antiapoptotic function in response to anticancer drug in prostate cancer. | Q40304129 |
| | A lactosylated steroid contributes in vivo therapeutic benefits in experimental models of mouse lymphoma and human glioblastoma | Q40310064 |
| | Cell surface counter receptors are essential components of the unconventional export machinery of galectin-1. | Q40358358 |
| | Galectin-1: a link between tumor hypoxia and tumor immune privilege | Q40362866 |
| P275 | copyright license | Creative Commons Attribution 2.5 Generic | Q18810333 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | brain tumor | Q233309 |
| | glioma | Q1365309 |
| | Galectin, carbohydrate recognition domain, protein family | Q83138026 |
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 17-27 | |
| P577 | publication date | 2009-04-07 | |
| | 2010-01-01 | |
| P1433 | published in | Brain Pathology | Q4955776 |
| P1476 | title | Galectins and gliomas | |
| P478 | volume | 20 | |